NAS to review anthrax evidence

The Federal Bureau of Investigation (FBI) yesterday (September 16) announced it will turn over scientific evidence against their chief suspect in the 2001 anthrax attacks, a US army microbiologist who linkurl:committed suicide;http://www.the-scientist.com/blog/display/54907/ in July, to scientists at the National Academy of Sciences (NAS) for independent review. Bruce Ivins, a researcher at the U.S. Army Medical Institute for Infectious Disease at Fort Detrick, Md, conducted studies on anthrax

Written byAlla Katsnelson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
The Federal Bureau of Investigation (FBI) yesterday (September 16) announced it will turn over scientific evidence against their chief suspect in the 2001 anthrax attacks, a US army microbiologist who linkurl:committed suicide;http://www.the-scientist.com/blog/display/54907/ in July, to scientists at the National Academy of Sciences (NAS) for independent review. Bruce Ivins, a researcher at the U.S. Army Medical Institute for Infectious Disease at Fort Detrick, Md, conducted studies on anthrax vaccines and was involved in analyzing samples for the FBI in its investigation of the attacks, which killed five people, sickened 17, and created chaos around the country. He committed suicide on July 29, as FBI officials prepared to indict him as the sole culprit in the attacks. In the weeks that followed, FBI officials released evidence showing how scientists working on the investigation had used DNA fingerprinting to trace the anthrax spores to a flask in Ivins' laboratory. However, some scientists, lawmakers, and members of the public have expressed skepticism, calling on the agency to be more transparent with the details of the investigation, noting the circumstantial nature of the evidence against Ivins, and suggesting that he had been scapegoated by the agency. The FBI and the NAS had been discussing the possibility of an NAS review for the past few weeks, and FBI Director Robert Mueller said yesterday in a House Judiciary Committee hearing that the agency would ask NAS to review the evidence. He said that with more than 60 non-FBI scientists having participated in the investigation, the scientific evidence had been vetted by researchers, but that the review would resolve some lingering scientific questions, linkurl:according to ScienceNOW.;http://sciencenow.sciencemag.org/cgi/content/full/2008/916/1 Vahid Majidi, the head of FBI's Weapons of Mass Destruction directorate, told ScienceNOW that the agency is putting together a document outlining the scope of the NAS review, and said that the agency intends "to share all of our scientific evidence with the reviewers." NAS reviews generally take about six to 18 months to complete, NAS spokesperson Bill Kearney linkurl:told the AP,;http://ap.google.com/article/ALeqM5gBlAAdzjtMryYGvNIIVF1k02ZFMwD93835P80 and a study of the type required in this case could cost anywhere from several hundred thousand dollars to $1 million of federal funds.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies